Gerry Chillè is a co-founder and chief strategy and innovation officer of Newel Health, where he leads the research, development and commercial strategies of the company’s Digital Therapeutics (DTx) products pipeline. A frequent presenter at health innovation conferences and an advisor on committees that inform and steer the industry’s adoption of digital therapeutic solutions, Mr. Chillè is also a guest lecturer at Johns Hopkins University Carey School of Business. In these lectures, he covers emerging trends and industry dynamics of digital therapeutics and their impact on health economic models.